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Succinylcholine-Induced Hyperkalemia In Children:  
The Case That Led To The Studies 
Background: Since its introduction into clinical practice in the early 1950s, succinylcholine 
rapidly became the gold standard for rapid onset of profound muscle relaxation and became an 
integral component of the standard anesthetic induction sequence for tracheal intubation.   Side 
effects of succinylcholine, however, soon became evident.  The first identifiable side effect was 
prolonged muscle relaxation that was ultimately correlated with delayed drug metabolism caused 
by abnormal plasma cholinesterase.  By the late 1950s, there were reports of cardiac arrest in 
burn patients following succinylcholine administration that were eventually found to be 
secondary to hyperkalemia.  Reports of succinylcholine-induced hyperkalemia in patients with 
neurologic diseases in the early 1970s led to warnings about the potential for hyperkalemia in 
many neurologic disorders, including children with cerebral palsy (CP) and myelomeningocele 
(MM).  We had used succinylcholine in many patients with CP or MM without adverse effect 
and had discussed on many occasions the need to formally study this.  Eventually, we had a case 
that stimulated us to proceed with a series of studies.   
Case Report:  The patient was a two-year-old male with severe developmental delay who 
presented for cataract extraction (March 1, 1983).  His hospital chart was extensive and every 
clinic note stated that he had cerebral palsy with spastic quadriplegia.  He was evaluated the day 
before surgery and the plan for general anesthesia discussed with his mother.  Prior to induction, 
an intravenous catheter was inserted after dermal anesthesia with lidocaine with a 30 gauge 
needle.  Induction was performed with atropine, thiopental and succinylcholine.  Soon after the 
injection of succinylcholine, peaked T waves developed on the ECG followed by widening of the 
QRS complex and onset of ventricular tachycardia.  Tracheal intubation was performed, closed 
chest massage was initiated and calcium chloride was administered intravenously.  The ECG 
quickly returned to normal and vital signs stabilized.  A potassium level obtained several minutes 
after the ECG change had reverted to normal was 8.1 mEq/L.  Surgery proceeded without 
incident and the patient was extubated several hours later in the PACU.  Several hours after 
release from the PACU, he developed respiratory distress and was intubated and transferred to 
the ICU.  A creatine kinase (CK) level obtained in the ICU the day after surgery was 22,620.  It 
was suggested to the patient’s neurologist that the patient might have a primary myopathy. The 
neurologist felt that the CK elevation was secondary to the cardiac arrest.  He remained in the 
ICU for 10-14 days and was discharged from the hospital on March 24, 1983.   In July, 1983 he 
underwent a muscle biopsy utilizing local anesthesia and the diagnosis of muscular dystrophy 
was made.  
Conclusion: Based on this experience, we decided to proceed with formal studies on the effect 
of succinylcholine on plasma potassium in normal children and children with CP or MM.  These 
studies were published in 1984 (normal), 1985 (CP), and 1986 (MM).  All three studies showed 
no significant change in plasma potassium levels after succinylcholine.
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